Stability of Poly(ε-caprolactone) Microparticles Containing Brucella ovis Antigens as a Vaccine Delivery System Against Brucellosis
- 16 October 2008
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 9 (4) , 1063-1069
Abstract
In previous works, our research group has successfully proved the use of subcellular vaccines based on poly(ε-caprolactone) (PEC) microparticles containing an antigenic extract of Brucella ovis (HS) against experimental brucellosis in both mice and rams. However, the successful exploitation of pharmaceutical products, and therefore of this product as veterinary vaccine, requires preservation of both biological activity and native structure in all steps of development from purification to storage. In this context, we have carried out an accelerated stability study to evaluate the relative stability of HS when loading in PEC microparticles. For this purpose, freeze-dried microparticles were stored at 40 ± 1°C and 75% RH as a preliminary analysis of a stability testing. The results showed that both physico-chemical (size, morphology, antigen content, release profile) and biological (integrity and antigenicity of the HS) properties were preserved after 6 months of storage. On the contrary, after 1 year of storage, the HS release profile was dramatically affected probably due to a progressive loss of the polymer microstructure. In addition, the degradation and loss of the antigenicity of the HS components was also evident by SDS-PAGE and immunoblotting analysis. In fact, after 12 months of storage, only the integrity and antigenicity of two of the major protective proteins of the HS antigenic complex were preserved.Keywords
This publication has 26 references indexed in Scilit:
- Thermal Degradation of Environmentally Degradable Poly(hydroxyalkanoic acid)sMacromolecular Bioscience, 2006
- Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in miceVaccine, 2006
- Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in ramsVaccine, 2006
- How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-β-cyclodextrin systemJournal of Controlled Release, 2005
- A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogsJournal of Controlled Release, 2004
- Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheresJournal of Controlled Release, 2003
- Polyester Microparticles as a Vaccine Delivery System for Brucellosis: Influence of the Polymer on Release, Phagocytosis and ToxicityJournal of Drug Targeting, 2002
- The effect of solvent removal conditions on performance and release property of protein-loaded microparticlesJournal of Microencapsulation, 2002
- The preparation, characterization and pre-clinical evaluation of an orally administered HIV-I vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticlesJournal of Controlled Release, 1995
- Evaluation of whole cell and subcellular vaccines against Brucella ovis in ramsVeterinary Immunology and Immunopathology, 1993